Info Session: Vertex Pharmaceuticals, May 3
Join us for an Employer Informational Session featuring Vertex Pharmaceuticals on Thursday, May 3, at 10:30am, in Light Hall 512.
Vertex will provide a quick info session / Q&A, and then leave the rest of the day to meet with any interested students or postdocs to discuss research, careers, and beyond. Attendees are encouraged to bring CVs or resumes to the session.
The info session will feature Tim Senter, Research Scientist II in Medicinal Chemistry; Leslie Dakin, Associate Director of Medical Chemistry; and Peter Jones, Director of Chemistry.
The info session will also provide info on the Vertex Summer Interns Program for primarily undergraduates and some graduate students in nearly all disciplines. Info for this can be found through this link: https://www.vrtx.com/working-here/university-relations.
Attendees with strong interest are encouraged to meet with Dr. Senter outside of the info session and can do so by reaching out directly to set up a time to meet throughout the day (firstname.lastname@example.org).
About Tim Senter:
I graduated with a bachelor’s degree in chemistry from St. Lawrence University in 2010, and then moved on to Vanderbilt University to begin my Ph.D. studies in organic chemistry in the lab of Prof. Craig Lindsley. During my time there I performed research in organic synthesis methodology, natural products total synthesis, and medicinal chemistry. After graduating in 2015, I pursued a postdoctoral fellowship at MIT with Prof. Stephen Buchwald studying bioconjugation chemistry and the design and synthesis of antibody-drug conjugates. In 2016 I started at Vertex as a research scientist in medicinal chemistry. I believe that I owe a lot to the interdisciplinary research experience that is really unique to Vanderbilt and VUMC, and exposure to this type of environment is becoming increasingly desirable to biotech and pharmaceutical companies.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and offices around the world. For several consecutive years, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the Company, please visit www.vrtx.com.
Vertex is currently hiring entry level positions across multiple fields in biomedical/life sciences.
Most are at the Ph.D. level, and span quite a few different areas.
Below are some examples of open positions:
Research Scientist I, Medicinal Chemistry-
Scientist I, Process Chemistry-
Research Scientist, Compound Purification –
Scientist, Analytical Development-
Research Scientist I, Human Biology-
Research Scientist, DMPK-
Research Scientist I, Computation Genomics-
Physician Scientist (M.D./Ph.D.)-